Monoclonal antibodies: new chance in the management of B-cell acute lymphoblastic leukemia.

Shi, Zheng; Zhu, Yiqian; Zhang, Jing; Chen, Baoan

Shi, Zheng; Zhu, Yiqian; Zhang, Jing; Chen, Baoan.

Affiliation

Shi Z; Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China.
Zhu Y; Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China.
Zhang J; Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China.
Chen B; Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China.

Hematology ; 27(1): 642-652, 2022 Dec.

Article in En | MEDLINE | ID: mdl-35622074

Subject(s)

Antineoplastic Agents, Immunological; Antineoplastic Agents; Burkitt Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents/therapeutic use; Antineoplastic Agents, Immunological/therapeutic use; Burkitt Lymphoma/drug therapy; Humans; Inotuzumab Ozogamicin; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy

Key words

Acute lymphoblastic leukemia; Inotuzumab Ozogamicin; adult; blinatumomab; monoclonal antibodies; ofatumumab

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Burkitt Lymphoma / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Antineoplastic Agents, Immunological / Antineoplastic Agents Type of study: Systematic_reviews Limits: Humans Language: En Journal: Hematology Year: 2022 Document type: Article

Fulltext

XML

PubMed Links

Search on Google